 FOSTER CITY, Calif., Aug. 11, 2021 GLOBE NEWSWIRE -- Vaxcyte, Inc. Nasdaq: PCVX, a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide, today announced financial results for the second quarter ended June 30, 2021 and provided a business update. 